Charcot-Marie-Tooth Disease Type 1 Caused by Mutation in MPZ

Charcot-Marie-Tooth disease type 1 caused by mutation in MPZ is a long-lasting, inherited nerve disease that mainly damages the nerves in the arms and legs. It is a demyelinating neuropathy, which means the covering (myelin) of the nerves is damaged, so nerve signals travel more slowly. Genetic Diseases Info Center+1

Charcot-Marie-Tooth disease type 1 (CMT1) is a group of inherited nerve diseases that damage the peripheral nerves. These nerves carry messages from the brain and spinal cord to the muscles and skin. In CMT1 due to MPZ mutation, the problem sits in a gene called MPZ (myelin protein zero). This gene gives the body instructions to make a major protein in the myelin sheath, the “insulating coat” around peripheral nerves. When MPZ is changed (mutated), the myelin is weak and unstable. Nerve signals become slow and confused, so muscles become weak and thin and feeling in the feet and hands slowly fades. NCBI+1

CMT1B is the most common MPZ-related subtype. It usually starts in childhood or early adulthood with high-arched feet, toe deformities, foot drop, frequent tripping, and later weakness in the hands. Reflexes are often reduced, and many people have burning or shooting neuropathic pain. The disease usually progresses slowly over many years. It does not usually shorten life, but it can strongly affect walking, balance, hand use and independence. NCBI+1

The MPZ gene (myelin protein zero) gives the body instructions to make the main protein in the myelin of the peripheral nerves. This gene is on chromosome 1 and is very close to an area called the Duffy locus. When MPZ is changed (mutated), the myelin cannot form or stay normal, and the nerve slowly stops working well. PMC+1

This disease mainly affects the peripheral nerves that carry messages between the spinal cord and the muscles and skin. People develop weakness and wasting of muscles in the feet, legs, hands, and sometimes arms, plus numbness or tingling. Symptoms usually grow very slowly over many years. NCBI+1

The condition is usually autosomal dominant. This means a person needs only one changed copy of the MPZ gene, from one parent, to have the disease. However, the age when symptoms start and how severe they are can be very different even inside the same family. Orpha.net+1

Other names and types

This disease is often called Charcot-Marie-Tooth disease type 1B (CMT1B) when it is clearly caused by MPZ mutations. CMT1B is a subtype of CMT1, which is the group of demyelinating forms of CMT. Genetic Diseases Info Center+1

Other names that may be used in reports or articles include “CMT due to MPZ mutation,” “MPZ-related CMT,” “MPZ-related hereditary motor and sensory neuropathy,” and sometimes “P0-related neuropathy,” because MPZ is also called P0. All these terms describe the same basic disease mechanism. PMC+1

CMT as a whole is also known as hereditary motor and sensory neuropathy (HMSN). CMT1 is the demyelinating type of HMSN, and CMT1B is one of its genetic sub-types, defined specifically by a mutation in the MPZ gene. NCBI+1

Within MPZ-related CMT, doctors sometimes talk about different clinical patterns or “phenotypes,” such as early-onset severe neuropathy, classical CMT that starts in childhood, or later-onset milder neuropathy. These differences are mostly related to the exact change in the MPZ gene and how that change alters the protein. PMC+1

Causes

1. Inherited MPZ gene mutation from a parent
The main cause is receiving one changed copy of the MPZ gene from a parent who also has CMT1B. Because this is usually autosomal dominant, each child has a 1 in 2 chance of inheriting the mutation if one parent is affected. Genetic Diseases Info Center+1

2. New (de novo) MPZ mutation
Sometimes the MPZ mutation happens for the first time in the egg or sperm, or very early after conception. In this case there is no family history, but the child still has CMT1B because the mutation is present in their cells. NCBI+1

3. Missense mutation in MPZ
A missense mutation changes one “letter” in the gene and swaps one amino acid in the protein. This small change can disturb how MPZ folds or sticks to other MPZ molecules, damaging the myelin and slowing nerve signals. PMC+1

4. Nonsense or truncating MPZ mutation
A nonsense or truncating mutation introduces a “stop” signal too early in the gene, making a shorter, incomplete protein. This abnormal protein often cannot function, leading to poorly formed myelin and more severe neuropathy. PMC+1

5. Frameshift mutation in MPZ
Frameshift mutations add or remove small pieces of DNA so the reading frame shifts. This usually produces a completely abnormal protein that may be quickly destroyed or may harm Schwann cells, causing myelin loss. PMC+1

6. Mutations affecting the extracellular (outer) part of MPZ
Changes in the outer part of MPZ can weaken its “glue” function, because MPZ normally helps myelin layers stick tightly together. Poor adhesion makes myelin unstable and easy to break down, leading to demyelination. PMC+1

7. Mutations affecting the cytoplasmic (inner) tail of MPZ
The tail of MPZ inside the Schwann cell helps organize the myelin and signals inside the cell. Mutations here can disturb signaling, cause abnormal myelin structure, and result in nerve conduction slowing. PMC+1

8. Misfolded MPZ protein in Schwann cells
Some mutations cause MPZ to fold incorrectly. Misfolded proteins can build up inside the cell’s endoplasmic reticulum and cause “stress,” eventually damaging Schwann cells and their ability to make healthy myelin. PMC+1

9. Toxic gain-of-function MPZ mutations
A few MPZ mutations do not simply reduce normal function but give the protein a harmful new behavior, such as clumping or interfering with other proteins. This toxic effect can strongly damage myelin. PMC+1

10. Loss-of-function MPZ mutations
Other mutations mainly cause loss of normal MPZ function. Because MPZ is the major myelin protein in peripheral nerves, losing its function means myelin is thin, poorly compacted, or missing, which slows nerve conduction. PMC+1

11. Early myelin development problems
Some MPZ mutations interfere with myelin formation very early in life. Children may show delayed walking, severe weakness, or foot deformities because their nerves never gain normal myelin thickness. Genetic Diseases Info Center+1

12. Later myelin degeneration
Other MPZ mutations allow almost normal early myelin, but the myelin then slowly breaks down over years. This leads to late-onset neuropathy, with symptoms starting in adulthood. PMC+1

13. Secondary axonal damage from myelin loss
When myelin is not healthy, the underlying axon (the long part of the nerve cell) is not protected. Over time, axons degenerate, worsening weakness and numbness. This secondary axonal damage is an important part of the disease. NCBI+1

14. Genetic background and modifier genes
Other genes in the person’s DNA can slightly increase or decrease the effect of an MPZ mutation. These “modifier” genes do not cause CMT by themselves but can change how severe the disease is. PMC+1

15. Rare combined mutations in more than one nerve gene
In rare families, a person may carry mutations in MPZ and in another CMT-related gene. Together, these changes can cause a more complex or severe neuropathy than would be expected from one mutation alone. NCBI+1

16. Parental germline mosaicism
Sometimes a parent has the MPZ mutation only in some of their egg or sperm cells and not in most body cells, so they seem healthy. This “mosaicism” can still lead to a child with CMT1B and explains some unexpected family cases. NCBI+1

17. Epigenetic changes affecting MPZ expression
Epigenetic changes (chemical marks on DNA) might influence how strongly the MPZ gene is turned on or off. They do not replace the main genetic mutation but may slightly modify disease severity in people with MPZ-related CMT. PMC+1

18. Co-existing medical problems that worsen nerve function
Conditions such as diabetes, vitamin B12 deficiency, or thyroid disease do not cause MPZ mutations, but they can add extra stress to already weak nerves, making symptoms worse and appearing like “extra” causes. NCBI+1

19. Physical stress on already weak nerves
Repeated ankle sprains, long-term pressure on nerves, or very heavy physical work can make symptoms of MPZ-related CMT worse. These stresses do not cause the disease but can trigger earlier or more visible problems. NCBI+1

20. Currently unknown mechanisms in some MPZ variants
New MPZ variants are still being discovered. For some of them, doctors know they are associated with CMT, but do not fully understand the precise molecular effect yet. Research is ongoing to clarify these mechanisms. PMC+1

Symptoms

1. Weakness in the feet and ankles
One of the earliest signs is trouble lifting the front of the foot, especially when walking upstairs or on uneven ground. This happens because the small muscles that lift the foot are getting weak. NCBI+1

2. Foot drop and high-stepping walk
Because the foot cannot lift properly, the person may catch their toes and trip. To avoid this, they lift their knees higher than normal, making a “high-stepping” or “steppage” gait. NCBI+1

3. High-arched feet (pes cavus)
Over time, the imbalance between weak and strong muscles in the foot leads to a high arch. This foot shape makes it harder to stand or walk for long periods and increases pressure on certain areas of the foot. orthobullets.com+1

4. Curled toes (hammertoes or claw toes)
The toes may bend at the joints and curl downwards. This can cause rubbing inside shoes, calluses, and pain. It also shows that the muscles controlling the toes are out of balance. orthobullets.com+1

5. Thinning of lower leg muscles (“stork legs”)
Muscles in the calves slowly shrink because they are not properly activated by the nerves. The lower legs look thin while the thighs look more normal, giving a “stork leg” appearance. NCBI+1

6. Weakness in the hands and fingers
Later in the disease, the small muscles of the hands can also become weak. Tasks like buttoning clothes, opening jars, writing, or using a phone may become more difficult. NCBI+1

7. Numbness in feet and hands
Many people feel reduced touch, vibration, or position sense in their feet and later in their hands. They may not feel small injuries on their toes or fingers as clearly as before. NCBI+1

8. Tingling or “pins and needles”
Abnormal nerve signals can cause tingling, prickling, or buzzing feelings, especially in the soles of the feet or fingertips. These sensations can be annoying, and sometimes they come and go. NCBI+1

9. Burning or neuropathic pain
Some patients develop burning pain, sharp stabbing pains, or electric-shock feelings in their feet or legs. This “neuropathic” pain is due to damaged nerves sending confused or extra signals. NCBI+1

10. Loss of reflexes (areflexia or hyporeflexia)
When the doctor taps the knee or ankle with a reflex hammer, the response may be very weak or absent. This happens because the reflex arc in the peripheral nerves is disrupted by demyelination. NCBI+1

11. Poor balance, especially in the dark
Because the nerves carrying position sense from the feet are damaged, it becomes harder to know where the feet are without looking. Balance is worse in the dark or with eyes closed. NCBI+1

12. Easy fatigue of leg muscles
Walking long distances, climbing stairs, or standing for a long time can cause early tiredness and aching in the legs, as the weakened nerves cannot keep the muscles working efficiently. Physiopedia+1

13. Difficulty running or jumping
Activities that need quick, strong movements of the feet and ankles, such as running, hopping, or jumping, become hard. Children may be slower than their peers in sports or physical education. NCBI+1

14. Spinal or skeletal deformities
Some patients develop scoliosis (curved spine) or other posture problems due to uneven muscle strength. These deformities can add to pain and functional problems. orthobullets.com+1

15. Emotional and social impact
Living with a chronic, progressive nerve disease can cause anxiety, sadness, or worry about the future. Changes in walking or hand function may also affect self-confidence and social activities. NCBI+1

Diagnostic tests

Physical exam and clinical assessment

1. Detailed neurological examination
A neurologist checks muscle strength, tone, reflexes, and sensation in arms and legs. In MPZ-related CMT1, they often find distal weakness, muscle wasting, reduced reflexes, and sensory loss in a “stocking-and-glove” pattern. NCBI+1

2. Gait and posture assessment
The doctor watches how the person walks, turns, and stands. A high-stepping gait, foot drop, and poor heel- or toe-walking give strong clues that a length-dependent peripheral neuropathy like CMT is present. NCBI+1

3. Examination of feet, legs, hands, and spine
The clinician looks for high arches, hammertoes, thin lower legs, hand muscle wasting, and possible scoliosis or other deformities. These visible signs support the diagnosis of a chronic inherited neuropathy. orthobullets.com+1

4. Family history and pedigree
The doctor draws a family tree over at least three generations, asking who had weakness, walking problems, or similar symptoms. An autosomal dominant pattern with multiple affected relatives suggests MPZ-related CMT1B or another CMT1 subtype. ScienceDirect+1

Manual and bedside functional tests

5. Manual muscle testing
Using simple resistance tests, the doctor grades the strength of key muscles in the feet, ankles, hands, and fingers. Typical findings include weak ankle dorsiflexion and toe extension, and later weak intrinsic hand muscles. NCBI+1

6. Balance and Romberg test
The patient is asked to stand with feet together and then close their eyes. If they sway or fall more with eyes closed, this suggests impaired position sense from peripheral neuropathy. NCBI+1

7. Heel-to-toe and tandem walking
Walking in a straight line placing one foot directly in front of the other tests coordination and balance. Difficulty with this test supports the presence of sensory ataxia from peripheral nerve damage. NCBI+1

8. Assessment of hand dexterity
Simple tasks like rapidly opening and closing the hand, picking up small objects, or buttoning and unbuttoning are used to see how much the hand muscles and fine motor skills are affected. NCBI+1

9. Clinical sensory testing
Using tools like a tuning fork for vibration, a monofilament for light touch, and pin-prick for pain, the doctor maps out where sensation is reduced. Length-dependent loss in feet and hands fits hereditary neuropathy. NCBI+1

Laboratory and pathological tests

10. Routine blood tests to rule out other neuropathies
Blood tests for glucose, vitamin B12, thyroid function, kidney and liver function help exclude acquired causes of neuropathy, such as diabetes or vitamin deficiency. Normal results support a genetic cause like MPZ-related CMT. NCBI+1

11. Specific genetic testing for MPZ
DNA testing of the MPZ gene looks for known or new mutations. A disease-causing MPZ variant plus matching clinical features confirms CMT1B. Testing can be done by targeted sequencing or as part of a CMT gene panel. MedlinePlus+1

12. Multi-gene next-generation sequencing panels
Because many genes can cause CMT, panels testing dozens of neuropathy genes are common. These panels often include MPZ and help distinguish CMT1B from other subtypes like PMP22-related CMT1A or GJB1-related CMTX1. Charcot-Marie-Tooth Association+1

13. Nerve biopsy (sural nerve biopsy)
In selected or unclear cases, a small sample of a sensory nerve from the leg is removed and studied under a microscope. In demyelinating CMT1, the biopsy may show thin myelin, onion-bulb formations, or other features linked to MPZ mutations. Today this is used less often because genetic testing is more available. PMC+1

Electrodiagnostic tests

14. Nerve conduction studies (NCS)
Electrodes are placed on the skin over nerves and muscles, and small electrical pulses are delivered. In CMT1B, motor and sensory nerve conduction velocities are usually slowed, consistent with demyelination, and this helps distinguish CMT1 from axonal forms. NCBI+1

15. Electromyography (EMG)
A thin needle electrode is inserted into muscles to measure their electrical activity. EMG can show signs of chronic denervation and re-innervation, confirming a long-standing neuropathy and helping rule out muscle diseases. NCBI+1

16. Somatosensory evoked potentials (SSEPs)
In some centers, SSEPs are used to measure how quickly sensory signals travel from the limb to the brain. Delayed responses support the presence of significant demyelination in the peripheral sensory pathways. NCBI+1

Imaging and structural tests

17. Foot and ankle X-rays
X-rays can show high arches, hammertoes, and other bone and joint changes. These images help orthopedic surgeons plan braces or surgery and show the long-term effect of muscle imbalance on the skeleton. orthobullets.com+1

18. MRI of lower legs or feet
Magnetic resonance imaging can show thinning of muscles and replacement by fat in the calves and feet. This pattern supports a chronic neuropathy and can help differentiate it from primary muscle diseases. NCBI+1

19. Nerve ultrasound (high-resolution nerve imaging)
Ultrasound can measure nerve size and structure. In demyelinating CMT, nerves may appear thickened. This non-invasive test is increasingly used as an additional tool in the assessment of hereditary neuropathies. Scientia Salut+1

20. Whole-body or targeted MRI for research and advanced cases
In some research settings, whole-body or targeted MRI is used to map which muscles are most affected and how quickly they change over time. This can help monitor disease progression and evaluate new treatments in trials. Scientia Salut+1

Non-Pharmacological Treatments (Therapies and Others)

Each point: description, purpose, mechanism in simple words. Evidence for these approaches comes from guidelines and reviews on CMT management. enmc.org+3ScienceDirect+3Scientia Salut+3

1. Individualized physical therapy
   Physical therapy uses stretching, strengthening, balance, and coordination exercises designed for each person. The goal is to keep muscles as strong and flexible as possible and maintain safe walking. It works by repeatedly training weak muscles, protecting joints, and teaching safer movement patterns so nerves and muscles work together more efficiently.

2. Ankle-foot orthoses (AFOs)
   AFOs are light braces for the ankle and foot that correct foot drop and ankle instability. Their purpose is to prevent tripping, improve walking style, reduce fatigue, and protect joints. They work by holding the ankle and foot in a stable position and helping the toes clear the ground during each step. Charcot-Marie-Tooth Association+1

3. Custom footwear and insoles
   Many people with CMT1B have very high arches or toe deformities. Custom shoes and insoles spread pressure evenly and support the arch. The purpose is to reduce pain, calluses, and ulcers and make walking more comfortable. They work by changing how weight is distributed across the sole and keeping the foot in a better alignment. ScienceDirect+1

4. Occupational therapy (OT)
   OT helps with hand weakness, poor grip and fine finger tasks. Therapists teach easier ways to dress, cook, write, and use computers, and may recommend special tools (thicker pens, adapted cutlery). The goal is to protect independence. It works by changing the task or the tool rather than forcing weak muscles to work too hard. ScienceDirect+1

5. Gait training and walking aids
   Gait training is supervised practice to improve step pattern, posture, and use of aids like canes or walkers. Purpose: reduce falls and increase walking distance. It works by teaching safer foot placement, encouraging heel-to-toe walking, and using aids to share weight and support balance. ScienceDirect+1

6. Balance and proprioception exercises
   These are exercises on stable and then slightly unstable surfaces, often with visual feedback. The purpose is to reduce falls and ankle sprains. They work by training the brain to rely more on vision and remaining sensory input to keep balance when the nerves in the feet are damaged. ScienceDirect+1

7. Podiatry and regular foot care
   A podiatrist trims nails safely, treats calluses and checks for early ulcers or infections. Purpose: prevent wounds that heal slowly because of reduced feeling. It works by catching small problems before they become serious and by advising on safe footwear and skin care. ScienceDirect+1

8. Stretching and joint-range exercises
   Daily gentle stretching of calves, hamstrings, and toe joints helps prevent contractures and stiffness. Purpose: maintain joint mobility and allow braces or shoes to fit correctly. They work by gradually lengthening tight muscles and soft tissues so the foot and ankle can still move into neutral positions. enmc.org+1

9. Energy conservation and fatigue management
   Therapists teach pacing, planning rests, and using aids (like rolling carts) to reduce fatigue. Purpose: keep people active without over-exhaustion. The mechanism is behavioral: avoid “boom and bust” cycles and spread physical load more evenly through the day. ScienceDirect+1

10. Pain psychology and cognitive-behavioural therapy (CBT)
    Chronic nerve pain and disability can cause anxiety and low mood. CBT helps change unhelpful thoughts, teaches relaxation techniques and coping plans. Purpose: reduce how much pain interferes with life. It works by changing brain responses to pain signals, even when the underlying nerve damage remains. ScienceDirect+1

11. Regular low-impact aerobic exercise
    Activities like swimming, cycling, or seated exercise can be safely adapted. Purpose: improve heart health, stamina, mood, and blood flow to nerves. They work by gently stressing the cardiovascular system without excessive strain on weak ankle and foot muscles. ScienceDirect+1

12. Weight management and nutrition counselling
    Extra body weight makes walking and balance more difficult and increases foot pressure. Balanced nutrition and maintaining a healthy weight reduce mechanical load and may improve mobility. The mechanism is simple: less mass to move, less stress on deformed joints and braces. ScienceDirect+1

13. Home safety and falls-prevention modifications
    Removing loose rugs, adding grab rails, night lights and non-slip mats can strongly cut fall risk. Purpose: reduce fractures and head injury. These changes work by removing environmental hazards that interact with weak muscles and poor sensation. ScienceDirect+1

14. Sleep and breathing support (e.g., CPAP if needed)
    Some people with CMT have breathing muscle weakness or sleep apnea. Sleep studies and devices like CPAP can help. Purpose: better sleep, less daytime fatigue, and protection for the heart and brain. They work by keeping the airway open and improving oxygen levels during sleep. NCBI+1

15. Genetic counselling
    Genetic counselling explains the specific MPZ mutation, inheritance pattern and reproductive options (such as pre-implantation or prenatal testing). Purpose: informed family planning and understanding of prognosis. It works by giving clear, accurate risk information to affected individuals and relatives. NCBI+2Dove Medical Press+2

16. Vocational and school counselling
    CMT1B can limit heavy physical work but many people can succeed in less physically demanding jobs. Vocational counselling helps identify suitable careers and workplace adjustments. It works by matching physical abilities with job demands and using accommodations like ergonomic tools or flexible hours. ScienceDirect+1

17. Assistive hand devices
    Simple devices like button hooks, zipper pulls, jar openers and built-up handles help when finger strength is reduced. Purpose: keep self-care and cooking independent. They work by using leverage, larger grip surfaces and mechanical advantage to reduce force needed from weak hand muscles. ScienceDirect+1

18. Peer support groups and patient organisations
    Groups such as CMT foundations connect people, share experience and up-to-date research. Purpose: emotional support, practical tips, and reduced isolation. They work by sharing knowledge and building a community that understands the condition. Charcot-Marie-Tooth Association+1

19. Specialist neuromuscular follow-up
    Regular follow-up with a neurologist or neuromuscular clinic allows early detection of changes, access to trials, and review of braces or surgery needs. Purpose: long-term monitoring and coordinated care. Mechanism: proactive rather than crisis-based management. NCBI+2Scientia Salut+2

20. Pre- and post-surgical rehabilitation
    Before and after orthopaedic surgery, targeted physiotherapy prepares muscles, protects the operated limb, and retrains walking. Purpose: maximise the benefit of surgery. It works by strengthening compensating muscles, teaching safe use of crutches, and gradually returning to normal activities. Charcot-Marie-Tooth Association+2enmc.org+2

---

Drug Treatments

There is no FDA-approved drug that cures or slows CMT1 due to MPZ mutation. Current medicines mainly target neuropathic pain, muscle symptoms, mood, and sleep. Recommendations below follow neuropathic pain guidelines and are consistent with information in FDA prescribing labels (for example pregabalin, gabapentin, duloxetine and amitriptyline) and major reviews. Charcot-Marie-Tooth Association+3PMC+3ScienceDirect+3

Typical doses mentioned are adult ranges; dosing must be individualized by a doctor and is different in children and teens.

1. Gabapentin (anticonvulsant)
   Gabapentin is widely used for neuropathic pain. Typical adult total dose is around 900–3,600 mg per day in divided doses. Purpose: reduce burning, tingling, and shooting pain in feet and hands. It works by binding to calcium channels in nerve cells, reducing abnormal firing that creates pain. PMC+1

2. Pregabalin (anticonvulsant)
   Pregabalin is a similar medicine with more predictable absorption. Usual adult dose is around 150–600 mg per day in divided doses. Purpose: treat nerve pain and improve sleep disturbed by pain. Mechanism: binds to α2δ subunit of calcium channels to reduce release of pain-related neurotransmitters. PMC+1

3. Duloxetine (SNRI antidepressant)
   Duloxetine is an antidepressant also approved for diabetic neuropathic pain. Typical adult dose is 30–60 mg once daily. Purpose: reduce neuropathic pain and help mood and anxiety. It works by increasing serotonin and noradrenaline in pain pathways in the brain and spinal cord. PMC+1

4. Amitriptyline (tricyclic antidepressant)
   Amitriptyline is an older antidepressant often used at low doses (10–75 mg at night) for neuropathic pain. Purpose: reduce burning pain and improve sleep. It blocks reuptake of serotonin and noradrenaline and has a sedative effect. Side effects include dry mouth, constipation, and drowsiness. PMC+1

5. Topical lidocaine patches
   Lidocaine 5% patches can be applied to small painful areas (for limited hours each day). Purpose: numb superficial nerve endings and reduce local pain without systemic effects. Mechanism: blocks sodium channels in nerve endings so pain signals do not start easily. PMC+1

6. Topical capsaicin cream or high-strength patch
   Capsaicin, derived from chili pepper, depletes substance P from nerve endings. Purpose: help local neuropathic pain, especially burning areas. It works by overstimulating pain fibres so they temporarily become less sensitive. Some people feel strong burning at first, which usually settles. PMC+1

7. Tramadol (weak opioid and SNRI)
   Tramadol is sometimes used as second-line treatment when first-line neuropathic pain medicines fail. Usual adult doses vary (e.g., 50–100 mg every 4–6 h up to a daily limit, under medical supervision). Purpose: reduce moderate to severe pain. It works on opioid receptors and also affects serotonin and noradrenaline. Risk: dependence, nausea, dizziness. PMC+1

8. NSAIDs (e.g., ibuprofen, naproxen)
   Non-steroidal anti-inflammatory drugs are not very effective for pure nerve pain but can help joint, muscle, and post-surgical pain in people with CMT. They reduce prostaglandins involved in inflammation. Side effects include stomach irritation, kidney strain, and increased bleeding risk at higher doses. ScienceDirect+1

9. Paracetamol (acetaminophen)
   Paracetamol is often used for mild background pain or in combination with other drugs. Purpose: lower general soreness and post-exercise aches. Mechanism is central, likely modulating pain pathways and temperature control, with less effect on inflammation. Overdose can severely harm the liver. ScienceDirect

10. Baclofen (antispasticity agent)
    Some people with CMT have muscle cramps or spastic-like tightness. Baclofen, often 5–20 mg taken three times daily in adults, reduces this. It acts on GABA receptors in the spinal cord to reduce muscle tone. Side effects can include drowsiness and weakness, so doses must be increased slowly. ScienceDirect+1

11. Tizanidine (muscle relaxant)
    Tizanidine can also treat painful muscle tightness. It works as an α2-adrenergic agonist in the spinal cord to decrease muscle spasm. Purpose: make movement and stretching easier. Side effects can include low blood pressure, dry mouth and sleepiness. ScienceDirect

12. Mexiletine (anti-arrhythmic used off-label for cramps)
    Mexiletine is a sodium-channel blocker sometimes used in neuromuscular diseases for troublesome cramps. It reduces abnormal muscle firing. Purpose: decrease frequency and intensity of cramps that disturb sleep and function. It must be used carefully because of possible heart rhythm and gastrointestinal side effects. ScienceDirect+1

13. Selective serotonin reuptake inhibitors (SSRIs) for mood
    Depression and anxiety are common in chronic neurological disease. SSRIs like sertraline are sometimes used. Purpose: improve mood, sleep and coping. They work by raising serotonin levels. Treating mood does not fix nerve damage but can greatly improve quality of life. Taylor & Francis Online

14. Sleep medicines (short-term, cautious use)
    Short-term sleep aids, such as melatonin or, in some adults, prescribed hypnotics, may be used when pain and discomfort cause severe insomnia. Purpose: restore sleep pattern. Mechanism: act on sleep-regulating pathways. They must be used carefully to avoid dependence and daytime sedation. Taylor & Francis Online

15. Anti-emetics and bowel medicines when needed
    Many neuropathic pain drugs cause nausea or constipation. Doctors may prescribe anti-emetic drugs or bowel regulators. The purpose is to manage side effects so pain treatment can continue safely. They work by acting on gut motility and nausea pathways. PMC+1

16. Vitamin D supplementation (if deficient)
    Vitamin D is sometimes prescribed when tests show deficiency, to support bone strength, especially in people with limited mobility or after surgery. It works by improving calcium absorption and bone mineralisation, which helps reduce fracture risk. ScienceDirect

17. High-dose vitamin C (ascorbic acid) – research only
    High-dose vitamin C was tested in CMT1A but did not show clear clinical benefit in large trials. It is not standard treatment for CMT1B but you may see it mentioned online. If used, it should be under study protocols. Purpose in trials was to modulate PMP22 expression; mechanism for MPZ disease is unclear. ScienceDirect+1

18. PXT3003 (baclofen + naltrexone + sorbitol; experimental)
    PXT3003 is an oral combination studied mainly in CMT1A. Phase III data showed promising improvement in disability, but it is not yet widely approved. Purpose: disease modification by acting on myelin-related pathways. Its exact mechanism involves combined low-dose repositioned drugs. It may become relevant for MPZ-related CMT in future trials. Charcot-Marie-Tooth Disease+4ClinicalTrials.gov+4PubMed+4

19. Analgesic topical NSAID gels
    For local joint or soft-tissue pain (for example after surgery), topical NSAID gels can be used. They work by delivering anti-inflammatory drug directly to the area with less systemic exposure. Purpose: reduce localized pain and swelling without high tablet doses. ScienceDirect

20. Medicines for co-existing conditions (e.g., diabetes, thyroid disease)
    If a person with CMT also has diabetes, thyroid problems, or vitamin deficiencies, treating these with appropriate drugs is crucial because they can worsen neuropathy. Purpose: remove extra nerve stressors so CMT effects are not amplified. HealthHub+3ScienceDirect+3AAFP+3

---

Dietary Molecular Supplements

No supplement has been proven to cure CMT1B, but some nutrients are studied in other neuropathies and may support general nerve health. Always discuss with a doctor, as high doses can have side effects or interact with medicines. IJBCP+3PMC+3European Review+3

1. Alpha-lipoic acid (ALA)
   ALA is an antioxidant used in some countries for diabetic neuropathy, often around 600 mg/day in adults. Purpose: reduce oxidative stress and possibly improve nerve conduction and pain. Mechanism: recycles other antioxidants and protects mitochondria. Evidence shows modest benefit for neuropathic pain, but data in CMT are lacking. PMC+2ScienceDirect+2

2. Acetyl-L-carnitine (ALC)
   ALC is involved in mitochondrial energy production and has been studied in chemotherapy-induced neuropathy. Doses in studies often range around 1–3 g/day. Purpose: support nerve regeneration and reduce pain. It works by transporting fatty acids into mitochondria and may support nerve repair, but results are mixed. European Review+2ClinicalTrials.gov+2

3. Omega-3 fatty acids (EPA/DHA)
   Omega-3 from fish oil or algae has anti-inflammatory and neuroprotective properties. Typical supplemental doses vary from about 500–2,000 mg EPA+DHA daily. Purpose: support nerve membrane health and reduce inflammation. Animal studies show improved nerve regeneration after injury with higher omega-3 levels. Understanding Animal Research+4PMC+4Omegor.com+4

4. Vitamin B12 (cyanocobalamin or methylcobalamin)
   Vitamin B12 is essential for myelin and nerve function. In deficiency, doses may be high (hundreds to thousands of micrograms), orally or by injection, under medical supervision. Purpose: correct deficiency and prevent extra neuropathy. Mechanism: supports myelin synthesis and DNA production. HealthHub+4NCBI+4Cleveland Clinic+4

5. B-complex / benfotiamine (vitamin B1 derivative)
   Benfotiamine and other B vitamins support nerve metabolism. Purpose: reduce neuropathic symptoms in some diabetic neuropathy studies. They work as co-enzymes in energy pathways in nerves. Evidence is mixed and mainly outside CMT, but correcting any deficiency is reasonable. IJBCP

6. Coenzyme Q10 (CoQ10)
   CoQ10 is part of the mitochondrial electron transport chain. Supplemental doses are often 100–300 mg/day. Purpose: support energy production in nerve and muscle cells and reduce oxidative stress. Mechanistically, it helps electron transfer and acts as an antioxidant. Evidence in CMT is limited. IJBCP

7. Vitamin D
   Vitamin D supports bone and muscle function. If blood levels are low, doctors may prescribe 800–2,000 IU/day or more for repletion. Purpose: prevent bone loss and fractures, especially when mobility is reduced. Mechanism: improves calcium absorption and bone mineralization. AAFP

8. Magnesium
   Magnesium is involved in nerve and muscle excitability. Supplementing low levels may help reduce cramps and improve sleep. Typical dietary supplement doses are around 200–400 mg/day. It works as a cofactor in many enzymatic reactions, including those controlling muscle contraction. Excess can cause diarrhoea. IJBCP

9. Curcumin (from turmeric)
   Curcumin has antioxidant and anti-inflammatory effects in experimental models. It may be taken as standardized extracts with piperine to improve absorption. Purpose: lower inflammation and oxidative stress. Mechanism: modulates NF-κB and other inflammatory signalling pathways. Clinical evidence in neuropathy is still limited. IJBCP

10. Probiotics and general multivitamins
    For people with limited diet or gut problems, a balanced multivitamin and probiotics may support overall health, immunity, and digestion. Purpose: ensure adequate intake of micronutrients needed for nerve and muscle functions. Mechanism: fills dietary gaps and modulates gut–immune interactions. Evidence is general, not specific to CMT. IJBCP+1

---

Immunity-Booster / Regenerative / Stem-Cell-Related Approaches

These are not standard treatments for MPZ-related CMT1 today. They are mainly in research or early trials and are only available inside carefully controlled studies. AFM Téléthon+3CMT Research Foundation+3ScienceDirect+3

1. Neurotrophin-3 (NT-3) protein or gene therapy
   NT-3 is a growth factor that supports Schwann cell survival and myelination. In mouse models and small human studies of CMT1A, NT-3 improved nerve regeneration and sensory function. Gene therapy using AAV vectors to deliver NT-3 is under study. Purpose: directly boost nerve repair; mechanism: enhance axon regeneration and remyelination. OUP Academic+4PubMed+4ScienceDirect+4

2. Gene therapy targeting MPZ mutations
   Researchers are developing viral-vector gene therapies that either replace defective genes, silence toxic ones, or edit the DNA. For MPZ-related CMT1B, strategies aim to repair or silence the mutant MPZ copy while preserving normal function. Purpose: correct the root genetic cause. Mechanism: uses AAV or other vectors to deliver healthy gene versions or gene-editing tools. Nature+3CMT Research Foundation+3ASGCT+3

3. Other CMT gene-replacement programmes
   Work on CMT type 4C and CMT1X using AAV-mediated gene replacement shows that correcting Schwann-cell genes can improve myelination and nerve conduction in animals. These successes support the idea that similar strategies may one day be used for MPZ disease. PMC+2Nature+2

4. Regenerative gene therapy for neuropathy (e.g., VM202/Engensis)
   Engensis (VM202) is a plasmid-DNA gene therapy that delivers hepatocyte growth factor and is being tested in diabetic neuropathy and early-phase trials in CMT. Purpose: promote angiogenesis and neuroregeneration. Mechanism: HGF supports nerve blood supply and survival pathways. Wikipedia+1

5. Mesenchymal stem-cell–based trials
   Some experimental protocols use mesenchymal stem cells to release growth factors and modulate inflammation in peripheral neuropathies. Purpose: create a supportive environment for nerve repair. Mechanism: paracrine signalling rather than direct replacement of nerve cells. Evidence is very early and not specific for MPZ CMT. ScienceDirect+1

6. Immune-modulating therapies in overlapping or misdiagnosed cases
   Rarely, patients initially labelled as CMT may have or develop immune-mediated neuropathies like CIDP, where treatments such as IVIG or steroids are effective. In true genetic CMT1B, these are generally not useful. The key mechanism is reducing autoimmune attacks on myelin, but this applies to inflammatory neuropathies, not classic MPZ disease. NCBI+2ScienceDirect+2

---

Surgeries (Procedures and Why They Are Done)

Surgery aims to correct fixed deformities, improve function and reduce pain when braces and therapy are not enough. ScienceDirect+4Charcot-Marie-Tooth Association+4PMC+4

1. Tendon transfer surgery
   In CMT feet, some muscles are weak and others pull too strongly, causing claw toes and twisted feet. Surgeons can move tendons from stronger muscles to weaker ones to rebalance forces. Purpose: improve foot alignment and active dorsiflexion, reduce deforming pull, and make walking smoother.

2. Osteotomy (bone-cutting and realignment)
   High-arched “cavovarus” feet are common in CMT1. Osteotomies reshape or shift foot bones, often the first metatarsal and calcaneus, to create a flatter, plantigrade foot. Purpose: correct rigid deformity, improve weight bearing, and delay joint damage.

3. Soft-tissue lengthening and release
   Tight structures like Achilles tendon, plantar fascia or toe flexors can be surgically lengthened or released. Purpose: allow the foot to come closer to neutral, reduce toe clawing, and improve brace fitting. Mechanism: reduces abnormal tension that locks the foot in a deformed position. Charcot-Marie-Tooth Association+1

4. Joint fusion (arthrodesis) in severe deformity
   When joints are badly deformed and unstable, surgeons may fuse them (often triple arthrodesis in the hindfoot). Purpose: create a stable, pain-free platform when motion is already poor. Mechanism: bones are fixed together so they no longer move painfully but can bear weight more reliably. PMC+2nmd-journal.com+2

5. Spinal or nerve decompression surgery (selected cases)
   Some adults with CMT have scoliosis or nerve entrapments such as carpal tunnel syndrome. Spinal fusion or nerve decompression may be offered when symptoms are severe and conservative care fails. Purpose: relieve nerve compression and prevent further disability. NCBI+1

---

Key Prevention and Protection Strategies

You cannot prevent being born with an MPZ mutation, but you can prevent or delay complications:

1. Genetic counselling before having children. NCBI+1

2. Early use of braces and therapy to avoid severe deformities. ScienceDirect+1

3. Daily foot checks for cuts, blisters, and infections. ScienceDirect+1

4. Prompt treatment of minor injuries to avoid ulcers.

5. Avoiding smoking, which harms blood flow to nerves. IJBCP

6. Strict control of diabetes or other metabolic diseases that worsen neuropathy. AAFP

7. Safe home environment to reduce falls (good lighting, rails, no loose rugs). enmc.org

8. Keeping up with vaccinations to reduce severe infections that might cause long bed rest and deconditioning.

9. Regular neuromuscular follow-up to detect scoliosis or worsening deformities early. Scientia Salut+1

10. Avoiding very toxic neurotoxic drugs when safer alternatives exist (for example some chemotherapy or high-dose alcohol misuse), always under medical advice. ScienceDirect+1

---

When to See Doctors

You should see a neurologist or neuromuscular specialist if you notice:

• New or worsening foot drop, frequent trips, or falls.

• High arches, claw toes, or a clear change in foot shape.

• Progressive numbness or burning pain in feet or hands.

• Sudden step-change in weakness (for example, rapid decline over weeks), which might signal another problem on top of CMT. NCBI+1

Urgent review is needed if there is:

• Rapidly progressive weakness, problems breathing, or trouble swallowing.

• Deep infection, spreading redness, or open ulcers on the feet.

• Severe unrelieved pain despite medicines.

Regular follow-ups (often yearly or as advised) help adjust braces, review surgery need, and monitor for new therapies or trials such as PXT3003 or gene-therapy studies. Scientia Salut+2ScienceDirect+2

(For you as a teen: never change medicines or supplements without a parent/guardian and your doctor.)

---

Simple Diet Do and Don’t Points

What to eat (5 points)

1. Plenty of fruits and vegetables – give vitamins, minerals, and antioxidants that support general health and immune function. IJBCP

2. Lean proteins (fish, eggs, beans, lean meat) – provide amino acids needed for muscle repair and nerve proteins like myelin.

3. Healthy fats, especially omega-3 rich foods (fatty fish, walnuts, flaxseed) – may support nerve membranes and reduce inflammation. PMC+1

4. Whole grains instead of refined grains – stabilise blood sugar, which is good for nerve health, especially if diabetes risk is present. AAFP

5. Adequate calcium and vitamin D foods (dairy, fortified plant milks, some fish) – important for bones when mobility is limited. AAFP

What to avoid or limit (5 points)

6. Excess added sugar and sugary drinks – raise blood sugar and long-term diabetes risk, which can worsen neuropathy. AAFP

7. Heavy alcohol use – directly toxic to peripheral nerves and can create an additional neuropathy on top of CMT. IJBCP

8. Very high saturated and trans fats – contribute to cardiovascular disease, which reduces blood flow to nerves and muscles.

9. Crash diets or very low-nutrient “fad” diets – risk vitamin deficiencies (B12, folate, etc.) that can further damage nerves. AAFP+1

10. Mega-doses of supplements without supervision – even “natural” products like ALA or B12 can have side effects or interact with medicines if doses are too high. PMC+2ScienceDirect+2

---

Frequently Asked Questions (FAQs)

1. Is Charcot-Marie-Tooth disease type 1 due to MPZ mutation curable?
   No. At present, there is no cure and no drug proven to stop or reverse CMT1B. Treatment focuses on symptoms, maintaining function and preventing complications with braces, therapy, surgery, and pain medicines. Research into gene and growth-factor therapies is ongoing. Wiley Online Library+3www.elsevier.com+3ScienceDirect+3

2. Does everyone with MPZ mutation become severely disabled?
   Severity varies widely, even within the same family. Some people have mild symptoms for life, while others need braces or surgery and may use a cane or wheelchair for longer distances. Most people retain independence with proper management and support. NCBI+1

3. Can exercise make my CMT worse?
   Appropriate, low-impact exercise is usually helpful and does not speed up the genetic disease. Over-exercising to the point of frequent injury or extreme fatigue can cause setbacks, so plans should be designed with a therapist. ScienceDirect+1

4. What is the role of surgery in CMT1B?
   Surgery is used when deformities become rigid, painful, or severely affect walking despite braces and therapy. It aims to create a more normal foot shape and balance, not to cure the nerve disease itself. Outcomes are generally good when performed by surgeons experienced in CMT. ScienceDirect+3Charcot-Marie-Tooth Association+3PMC+3

5. Will pain medicines like gabapentin or duloxetine fix the nerve damage?
   No. They mainly change how the nervous system processes pain signals, so pain feels less intense. The underlying MPZ-related myelin problem remains. That is why combining medicines with therapies and braces is important. PMC+2ScienceDirect+2

6. Are experimental treatments like PXT3003 or NT-3 available for me now?
   They may be available only within clinical trials, and many early trials focus on CMT1A rather than MPZ-related CMT1B. Access depends on your age, location, and trial criteria. A neuromuscular specialist or patient organisations can help identify opportunities. AFM Téléthon+5ClinicalTrials.gov+5PubMed+5

7. Do dietary supplements really help CMT?
   Some supplements (like ALA, ALC, omega-3 and B vitamins) show benefits in other neuropathies, especially diabetic neuropathy, but strong evidence in CMT is limited. They are best used to correct true deficiencies or as cautiously supervised add-ons, not as replacements for core therapies. AAFP+4PMC+4European Review+4

8. Will stem-cell therapy or gene editing be available soon?
   Stem-cell and gene-editing approaches for CMT, including MPZ disease, are promising in animal studies and early research, but they must pass many safety and effectiveness tests before routine use. For now, they are experimental and available only in limited trials. AFM Téléthon+4CMT Research Foundation+4ScienceDirect+4

9. Can a teenager with CMT1B play sports?
   Many teens with CMT can take part in adapted sports, especially low-impact ones like swimming or cycling. The key is to avoid heavy ankle stress, jumping from heights, or high-risk contact sports without proper support. A physiotherapist and doctor should guide safe choices. ScienceDirect+1

10. Does pregnancy make CMT worse?
    Some people report increased symptoms during pregnancy due to weight gain and fluid changes, but major permanent worsening is not universal. Women with CMT planning pregnancy should have pre-pregnancy counselling with neurology and obstetric teams. NCBI+1

11. Is CMT1B the same as CMT1A?
    No. CMT1A is usually caused by duplication of the PMP22 gene, while CMT1B is due to MPZ mutations. Clinically they overlap a lot, but age of onset and severity can differ. Treatment at present is similar because both lack disease-modifying drugs. NCBI+2Wikipedia+2

12. Should family members be tested for MPZ mutations?
    Genetic testing is often offered to relatives who show symptoms or are planning children. It should always be done with counselling so people understand results and implications. For minors, decisions are usually made case-by-case with parents and doctors. NCBI+1

13. Can CMT be misdiagnosed as another neuropathy?
    Yes. Early on, CMT can look like other neuropathies. Nerve conduction studies, EMG, and genetic testing help confirm diagnosis and distinguish CMT from acquired conditions like CIDP, which have different treatments. NCBI+2ScienceDirect+2

14. Why are my reflexes weak or absent?
    Because the myelin around peripheral nerves is damaged by the MPZ mutation, electrical signals travel slowly and reflex arcs do not fire normally. This is why ankle reflexes are often absent in CMT1 even when strength is still relatively good. NCBI+1

15. What is the most important thing I can do right now?
    The most important steps are: get a clear diagnosis with genetic confirmation, build a care team (neurologist, physio, OT, orthotist), wear appropriate braces or shoes, stay safely active, protect your feet, and look after your mental health. This combination gives the best chance to stay mobile and independent while research continues. enmc.org+3ScienceDirect+3Scientia Salut+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 25, 2025.